체외진단용 효소 시장 : 효소별, 질환별, 기술별, 최종 용도별, 국가별, 지역별 - 세계 업계 분석, 시장 규모, 시장 점유율, 예측(2026-2033년)

In-vitro Diagnostics Enzymes Market size was valued at US$ 1,876.93 Million in 2025, expanding at a CAGR of 9.34% from 2026 to 2033.

In-Vitro Diagnostics (IVD) enzymes are specialized biological catalysts used to enable accurate biochemical reactions in diagnostic testing. The In-vitro Diagnostics Enzymes market is growing due to rising adoption of enzyme-based diagnostic tests in biotechnology and disease detection applications. For instance, research published in the IJERT Org. highlights that machine learning-based systems, particularly Convolutional Neural Networks (CNNs), are increasingly being adopted to improve disease diagnosis accuracy. The study indicates that CNN models improve disease detection from medical imaging with higher precision and more consistent results than traditional methods. These innovations are driving demand for advanced enzyme-based diagnostic technologies in healthcare.

In-vitro Diagnostics Enzymes Market- Market Dynamics

Advancements in Biotechnology and Molecular Diagnostics Driving Market Growth and Demand

The field of molecular diagnostics is advancing through high-sensitivity techniques that enable precise detection of DNA and RNA variations, improving disease identification and genetic analysis, along with the growing use of PCR-based systems, mass spectrometry, and multiplex platforms that enhance detection of infectious diseases, cancer biomarkers, and genetic disorders with greater accuracy and speed, while multi-parametric diagnostic approaches integrating molecular and imaging methods are further improving diagnostic specificity and enabling more comprehensive disease profiling.

Advancements in biotechnology and molecular diagnostics are driving the In-vitro Diagnostics Enzymes market. These developments are enabling higher accuracy, faster testing, and improved sensitivity in diagnostic assays for disease detection and monitoring. For instance, in 2025, research highlighted in NIH Gov. emphasizes that rapid advancements in biotechnology and molecular diagnostics are significantly transforming disease detection and clinical decision-making. The study notes that modern molecular diagnostic platforms such as PCR-based assays, NGS, CRISPR detection systems, and microfluidic lab-on-chip technologies have reduced diagnostic turnaround times from several days to just a few hours. These innovations have improved diagnostic sensitivity and specificity by over 90-95% in pathogen detection and cancer biomarker identification, enabling earlier and more accurate diagnosis.

In-vitro Diagnostics Enzymes Market- Segmentation Analysis:

The Global In-vitro Diagnostics Enzymes Market is segmented on the basis of Enzyme, Disease, Technology, End Use, and Region.

Based on enzymes, proteases occupy an important position in the In-vitro Diagnostics Enzymes market due to their widespread use in sample preparation, protein analysis, and diagnostic assay applications. In May 2025, F. Hoffmann-La Roche Ltd. launched the Elecsys(R) PRO-C3 test, a diagnostic assay designed to improve liver fibrosis assessment through advanced protein analysis and streamlined diagnostic workflows for enhanced in vitro diagnostics applications. This advancement strengthens proteases' role in improving in vitro diagnostics accuracy and efficiency.

In terms of disease application, infectious diseases represent the most significant segment in the In-vitro Diagnostics Enzymes market, driven by rising demand for rapid and accurate diagnostic testing. For instance, according to research published by the NCBI Bookshelf, the growing burden of infectious diseases and the limitations of conventional diagnostic methods are significantly increasing the demand for accurate diagnostic testing. The study highlights that fewer than 30% of patients with common urinary tract infection (UTI) symptoms were confirmed to have an actual infection, underscoring the need for more accurate diagnostic tools. Thus, advanced diagnostics improve accuracy and enhance clinical decision-making outcomes.

In-vitro Diagnostics Enzymes Market- Geographical Insights

North America holds a prominent position in the In-vitro Diagnostics Enzymes market, supported by a well-developed healthcare infrastructure and widespread adoption of advanced diagnostic technologies. For instance, based on the findings discussed in the US Gov, adoption of advanced diagnostic technologies in the United States is being shaped by a rapid transition toward molecular, imaging, and AI-assisted systems that improve speed, accuracy, and clinical decision-making. The study highlights that over recent years, advanced diagnostics such as molecular testing, point-of-care platforms, and digital/AI-enabled tools have shown steady integration into clinical workflows, particularly in hospital and specialized care settings, reflecting a broader modernization of diagnostic infrastructure in the U.S. This integration will enhance diagnostic efficiency and support sustained market growth.

On the other hand, Asia Pacific is witnessing market growth driven by rising chronic disease prevalence, increasing demand for early and accurate diagnosis, and higher healthcare spending. For instance, according to OECD.org, Japan's healthcare system is already among the most advanced and high-cost systems in the OECD, reflecting a steady and structural rise in healthcare expenditure driven by aging and medical demand. Japan allocated around 9.3% of its GDP to healthcare, broadly in line with the OECD average but significantly higher than pre-pandemic levels, when spending was closer to ~8.8% of GDP. Therefore, these trends reflect rising healthcare investment and diagnostic modernization growth.

U.S In-vitro Diagnostics Enzymes Market - Country Insights

The U.S. plays a key role in the In-vitro Diagnostics Enzymes market, supported by advanced healthcare infrastructure, research capabilities, and widespread adoption of diagnostic solutions. In June 2025, Dyadic International continued advancing its enzyme production technology platforms for healthcare and diagnostic applications, focusing on improving biomanufacturing efficiency and supporting the development of advanced enzymes used in in vitro diagnostic processes through ongoing research and development initiatives. These developments collectively strengthen innovation and efficiency in enzyme-based diagnostic solutions.

In-vitro Diagnostics Enzymes Market- Competitive Landscape:

The market is highly competitive, with companies focusing on innovation, product differentiation, and strategic collaborations to strengthen their positions. Firms such as Merck KGaA, Codexis, Inc., BBI Solutions, and F. Hoffmann-La Roche Ltd. are enhancing enzyme performance by improving specificity, stability, and shelf life to meet evolving diagnostic needs. Similarly, Amano Enzyme Inc. and Advanced Enzymes Technologies Ltd. are investing in R&D to develop high-performance enzymes compatible with molecular diagnostics, immunoassays, and clinical chemistry applications, while also focusing on regulatory approvals and quality standards for market expansion. In January 2026, Roche strengthened its in vitro diagnostics segment through continued investment in enzyme-based molecular diagnostic technologies, focusing on next-generation PCR and immunoassay platforms to support faster and more accurate disease detection. Hence, increasing innovation and strategic investments continue to drive strong competitive growth in the market.

Recent Developments:

In May 2025, Codexis, Inc. advanced its enzyme engineering platform by expanding strategic collaborations focused on developing high-performance enzymes for molecular diagnostics applications, enhancing sensitivity and efficiency in in vitro diagnostic workflows.

In March 2025, Merck KGaA expanded its diagnostics and life science portfolio by strengthening enzyme-based assay development capabilities through increased investment in advanced biocatalysis and molecular diagnostics research, aimed at improving precision and speed in in vitro diagnostic testing.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL IN-VITRO DIAGNOSTICS ENZYMES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

• Merck KGaA
• Codexis Inc.
• F. Hoffmann-La Roche Ltd.
• Amano Enzyme Inc.
• Advanced Enzymes Technologies Ltd.
• Biocatalysts Ltd.
• Amicogen Inc.
• Dyadic International Inc.
• BBI Solutions
• Affymetrix (Thermo Fisher Scientific)
• American Laboratories Inc.
• Others

GLOBAL IN-VITRO DIAGNOSTICS ENZYMES MARKET, BY ENZYME- MARKET ANALYSIS, 2020 - 2033

• Proteases
• Polymerase & Transcriptase
• Ribonuclease
• Others

GLOBAL IN-VITRO DIAGNOSTICS ENZYMES MARKET, BY DISEASE- MARKET ANALYSIS, 2020 - 2033

• Diabetes
• Oncology
• Cardiology
• Infectious disease
• HIV
• Hepatitis
• COVID-19 testing
• Others
• Nephrology
• Autoimmune diseases
• Others

GLOBAL IN-VITRO DIAGNOSTICS ENZYMES MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033

• Clinical Chemistry
• Molecular Diagnostics
• NGS Assays
• PCR Assays
• Others
• Histology Assays
• Others

GLOBAL IN-VITRO DIAGNOSTICS ENZYMES MARKET, BY END USE- MARKET ANALYSIS, 2020 - 2033

• Contract Research Organizations (CROs)
• Academic Labs
• Hospital & Diagnostic Labs
• Pharma & Biotech
• Others

GLOBAL IN-VITRO DIAGNOSTICS ENZYMES MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• The Netherlands
• Sweden
• Russia
• Poland
• Denmark
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Indonesia
• Thailand
• Philippines
• Taiwan
• Vietnam
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Turkey
• Algeria
• Egypt
• Iran
• Qatar
• Rest of MEA

Table of Contents

1. In-vitro Diagnostics Enzymes Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. In-vitro Diagnostics Enzymes Market Snippet by Enzyme
  • 2.1.2. In-vitro Diagnostics Enzymes Market Snippet by Disease
  • 2.1.3. In-vitro Diagnostics Enzymes Market Snippet by Technology
  • 2.1.4. In-vitro Diagnostics Enzymes Market Snippet by End Use
  • 2.1.5. In-vitro Diagnostics Enzymes Market Snippet by Country
  • 2.1.6. In-vitro Diagnostics Enzymes Market Snippet by Region
• 2.2. Competitive Insights

3. In-vitro Diagnostics Enzymes Key Market Trends

• 3.1. In-vitro Diagnostics Enzymes Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. In-vitro Diagnostics Enzymes Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. In-vitro Diagnostics Enzymes Market Opportunities
• 3.4. In-vitro Diagnostics Enzymes Market Future Trends

4. In-vitro Diagnostics Enzymes Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. In-vitro Diagnostics Enzymes Market : Impact of Escalating Geopolitical Tensions

• 5.1. Impact of COVID-19 Pandemic
• 5.2. Impact of Russia-Ukraine War
• 5.3. Impact of Middle East Conflicts

6. In-vitro Diagnostics Enzymes Market Landscape

• 6.1. In-vitro Diagnostics Enzymes Market Share Analysis, 2025
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. In-vitro Diagnostics Enzymes Market - By Enzyme

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Enzyme, 2025 & 2033 (%)
  • 7.1.2. Proteases
  • 7.1.3. Polymerase & Transcriptase
  • 7.1.4. Ribonuclease
  • 7.1.5. Others

8. In-vitro Diagnostics Enzymes Market - By Disease

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Disease, 2025 & 2033 (%)
  • 8.1.2. Diabetes
  • 8.1.3. Oncology
  • 8.1.4. Cardiology
  • 8.1.5. Infectious disease
    • 8.1.5.1. HIV
    • 8.1.5.2. Hepatitis
    • 8.1.5.3. COVID-19 testing
    • 8.1.5.4. Others
  • 8.1.6. Nephrology
  • 8.1.7. Autoimmune diseases
  • 8.1.8. Others

9. In-vitro Diagnostics Enzymes Market - By Technology

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By Technology, 2025 & 2033 (%)
  • 9.1.2. Clinical Chemistry
  • 9.1.3. Molecular Diagnostics
    • 9.1.3.1. NGS Assays
    • 9.1.3.2. PCR Assays
    • 9.1.3.3. Others
  • 9.1.4. Histology Assays
  • 9.1.5. Others

10. In-vitro Diagnostics Enzymes Market - By End Use

• 10.1. Overview
  • 10.1.1. Segment Share Analysis, By Disease, 2025 & 2033 (%)
  • 10.1.2. Contract Research Organizations (CROs)
  • 10.1.3. Academic Labs
  • 10.1.4. Hospital & Diagnostic Labs
  • 10.1.5. Pharma & Biotech
  • 10.1.6. Others

11. In-vitro Diagnostics Enzymes Market - By Geography

• 11.1. Introduction
  • 11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
• 11.2. North America
  • 11.2.1. Overview
  • 11.2.2. In-vitro Diagnostics Enzymes Key Manufacturers in North America
  • 11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 11.2.4. North America Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
  • 11.2.5. North America Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
  • 11.2.6. North America Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  • 11.2.7. North America Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.2.8. U.S.
    • 11.2.8.1. Overview
    • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.2.8.3. U.S. Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
    • 11.2.8.4. U.S. Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 11.2.8.5. U.S. Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.2.8.6. U.S. Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.2.9. Canada
    • 11.2.9.1. Overview
    • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.2.9.3. Canada Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
    • 11.2.9.4. Canada Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 11.2.9.5. Canada Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.2.9.6. Canada Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
• 11.3. Europe
  • 11.3.1. Overview
  • 11.3.2. In-vitro Diagnostics Enzymes Key Manufacturers in Europe
  • 11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 11.3.4. Europe Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
  • 11.3.5. Europe Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
  • 11.3.6. Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  • 11.3.7. Europe Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.3.8. Germany
    • 11.3.8.1. Overview
    • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.8.3. Germany Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
    • 11.3.8.4. Germany Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 11.3.8.5. Germany Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.8.6. Germany Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.3.9. UK
    • 11.3.9.1. Overview
    • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.9.3. UK Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
    • 11.3.9.4. UK Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 11.3.9.5. UK Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.9.6. UK Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.3.10. France
    • 11.3.10.1. Overview
    • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.10.3. France Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
    • 11.3.10.4. France Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 11.3.10.5. France Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.10.6. France Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.3.11. Italy
    • 11.3.11.1. Overview
    • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.11.3. Italy Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
    • 11.3.11.4. Italy Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 11.3.11.5. Italy Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.11.6. Italy Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.3.12. Spain
    • 11.3.12.1. Overview
    • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.12.3. Spain Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
    • 11.3.12.4. Spain Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 11.3.12.5. Spain Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.12.6. Spain Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.3.13. The Netherlands
    • 11.3.13.1. Overview
    • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.13.3. The Netherlands Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
    • 11.3.13.4. The Netherlands Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 11.3.13.5. The Netherlands Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.13.6. The Netherlands Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.3.14. Sweden
    • 11.3.14.1. Overview
    • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.14.3. Sweden Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
    • 11.3.14.4. Sweden Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 11.3.14.5. Sweden Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.14.6. Sweden Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.3.15. Russia
    • 11.3.15.1. Overview
    • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.15.3. Russia Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
    • 11.3.15.4. Russia Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 11.3.15.5. Russia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.15.6. Russia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.3.16. Poland
    • 11.3.16.1. Overview
    • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.16.3. Poland Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
    • 11.3.16.4. Poland Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 11.3.16.5. Poland Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.16.6. Poland Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.3.17. Denmark
    • 11.3.17.1. Overview
    • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.17.3. Poland Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
    • 11.3.17.4. Denmark Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 11.3.17.5. Denmark Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.17.6. Denmark Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.3.18. Rest of Europe
    • 11.3.18.1. Overview
    • 11.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.18.3. Rest of the Europe Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
    • 11.3.18.4. Rest of the Europe Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 11.3.18.5. Rest of the Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.18.6. Rest of the Europe Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
• 11.4. Asia Pacific (APAC)
  • 11.4.1. Overview
  • 11.4.2. In-vitro Diagnostics Enzymes Key Manufacturers in Asia Pacific
  • 11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 11.4.4. APAC Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
  • 11.4.5. APAC Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
  • 11.4.6. APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  • 11.4.7. APAC Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.4.8. China
    • 11.4.8.1. Overview
    • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.8.3. China Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
    • 11.4.8.4. China Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 11.4.8.5. China Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.8.6. China Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.4.9. India
    • 11.4.9.1. Overview
    • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.9.3. India Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
    • 11.4.9.4. India Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 11.4.9.5. India Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.9.6. India Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.4.10. Japan
    • 11.4.10.1. Overview
    • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.10.3. Japan Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
    • 11.4.10.4. Japan Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 11.4.10.5. Japan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.10.6. Japan Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.4.11. South Korea
    • 11.4.11.1. Overview
    • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.11.3. South Korea Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
    • 11.4.11.4. South Korea Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 11.4.11.5. South Korea Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.11.6. South Korea Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.4.12. Australia
    • 11.4.12.1. Overview
    • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.12.3. Australia Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
    • 11.4.12.4. Australia Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 11.4.12.5. Australia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.12.6. Australia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.4.13. Indonesia
    • 11.4.13.1. Overview
    • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.13.3. Indonesia Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
    • 11.4.13.4. Indonesia Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 11.4.13.5. Indonesia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.13.6. Indonesia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.4.14. Thailand
    • 11.4.14.1. Overview
    • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.14.3. Thailand Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
    • 11.4.14.4. Thailand Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 11.4.14.5. Thailand Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.14.6. Thailand Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.4.15. Philippines
    • 11.4.15.1. Overview
    • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.15.3. Philippines Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
    • 11.4.15.4. Philippines Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 11.4.15.5. Philippines Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.15.6. Philippines Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.4.16. Taiwan
    • 11.4.16.1. Overview
    • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.16.3. Taiwan Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
    • 11.4.16.4. Taiwan Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 11.4.16.5. Taiwan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.16.6. Taiwan Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.4.17. Vietnam
    • 11.4.17.1. Overview
    • 11.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.17.3. Vietnam Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
    • 11.4.17.4. Vietnam Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 11.4.17.5. Vietnam Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.17.6. Vietnam Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.4.18. Rest of APAC
    • 11.4.18.1. Overview
    • 11.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.18.3. Rest of APAC Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
    • 11.4.18.4. Rest of APAC Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 11.4.18.5. Rest of APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.18.6. Rest of APAC Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
• 11.5. Latin America (LATAM)
  • 11.5.1. Overview
  • 11.5.2. In-vitro Diagnostics Enzymes Key Manufacturers in Latin America
  • 11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 11.5.4. LATAM Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
  • 11.5.5. LATAM Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
  • 11.5.6. LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  • 11.5.7. LATAM Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.5.8. Brazil
    • 11.5.8.1. Overview
    • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.5.8.3. Brazil Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
    • 11.5.8.4. Brazil Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 11.5.8.5. Brazil Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.5.8.6. Brazil Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.5.9. Mexico
    • 11.5.9.1. Overview
    • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.5.9.3. Mexico Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
    • 11.5.9.4. Mexico Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 11.5.9.5. Mexico Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.5.9.6. Mexico Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.5.10. Argentina
    • 11.5.10.1. Overview
    • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.5.10.3. Argentina Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
    • 11.5.10.4. Argentina Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 11.5.10.5. Argentina Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.5.10.6. Argentina Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.5.11. Colombia
    • 11.5.11.1. Overview
    • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.5.11.3. Colombia Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
    • 11.5.11.4. Colombia Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 11.5.11.5. Colombia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.5.11.6. Colombia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.5.12. Rest of LATAM
    • 11.5.12.1. Overview
    • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
    • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
• 11.6. Middle East and Africa (MEA)
  • 11.6.1. Overview
  • 11.6.2. In-vitro Diagnostics Enzymes Key Manufacturers in Middle East and Africa
  • 11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 11.6.4. MEA Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
  • 11.6.5. MEA Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
  • 11.6.6. MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  • 11.6.7. MEA Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.6.8. Saudi Arabia
    • 11.6.8.1. Overview
    • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
    • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.6.9. United Arab Emirates
    • 11.6.9.1. Overview
    • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
    • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.6.10. Israel
    • 11.6.10.1. Overview
    • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.10.3. Israel Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
    • 11.6.10.4. Israel Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 11.6.10.5. Israel Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.10.6. Israel Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.6.11. Turkey
    • 11.6.11.1. Overview
    • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.11.3. Turkey Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
    • 11.6.11.4. Turkey Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 11.6.11.5. Turkey Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.11.6. Turkey Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.6.12. Algeria
    • 11.6.12.1. Overview
    • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.12.3. Algeria Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
    • 11.6.12.4. Algeria Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 11.6.12.5. Algeria Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.12.6. Algeria Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.6.13. Egypt
    • 11.6.13.1. Overview
    • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.13.3. Egypt Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
    • 11.6.13.4. Egypt Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 11.6.13.5. Egypt Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.13.6. Egypt Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.6.14. Iran
    • 11.6.14.1. Overview
    • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.14.3. Iran Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
    • 11.6.14.4. Iran Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 11.6.14.5. Iran Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.14.6. Iran Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.6.15. Qatar
    • 11.6.15.1. Overview
    • 11.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.15.3. Qatar Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
    • 11.6.15.4. Qatar Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 11.6.15.5. Qatar Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.15.6. Qatar Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 11.6.16. Rest of MEA
    • 11.6.16.1. Overview
    • 11.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.16.3. Rest of MEA Market Size and Forecast, By Enzyme, 2020 - 2033 (US$ Million)
    • 11.6.16.4. Rest of MEA Market Size and Forecast, By Disease, 2020 - 2033 (US$ Million)
    • 11.6.16.5. Rest of MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.16.6. Rest of MEA Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)

12. Key Vendor Analysis- In-vitro Diagnostics Enzymes Industry

• 12.1. Competitive Benchmarking
  • 12.1.1. Competitive Dashboard
  • 12.1.2. Competitive Positioning
• 12.2. Company Profiles
  • 12.2.1. Merck KGaA
  • 12.2.2. Codexis Inc.
  • 12.2.3. F. Hoffmann-La Roche Ltd.
  • 12.2.4. Amano Enzyme Inc.
  • 12.2.5. Advanced Enzymes Technologies Ltd.
  • 12.2.6. Biocatalysts Ltd.
  • 12.2.7. Amicogen Inc.
  • 12.2.8. Dyadic International Inc.
  • 12.2.9. BBI Solutions
  • 12.2.10. Affymetrix (Thermo Fisher Scientific)
  • 12.2.11. American Laboratories Inc.
  • 12.2.12. Others

13. 360 Degree AnalystView

14. Appendix

• 14.1. Research Methodology
• 14.2. References
• 14.3. Abbreviations
• 14.4. Disclaimer
• 14.5. Contact Us